Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10044531HBVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30004704HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30012505HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047381HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047382HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047383HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047384HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047385HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TVIS30047386HIVENSG00000126934.15protein_codingMAP2K2YesNo5605P36507
TCGA Plot Options
Drug Information
GeneMAP2K2
DrugBank IDDB08911
Drug NameTrametinib
Target IDBE0004744
UniProt IDP36507
Regulation Typeinhibitor
PubMed IDs23432625
CitationsSalama AK, Kim KB: Trametinib (GSK1120212) in the treatment of melanoma. Expert Opin Pharmacother. 2013 Apr;14(5):619-27. doi: 10.1517/14656566.2013.770475. Epub 2013 Feb 23.
GroupsApproved
Direct ClassificationPyridopyrimidines
SMILESCN1C(=O)C(C)=C2N(C(=O)N(C3CC3)C(=O)C2=C1NC1=CC=C(I)C=C1F)C1=CC(NC(C)=O)=CC=C1
Pathways
PharmGKBPA166115364
ChEMBLCHEMBL2103875